Glenda Gray to RNA, Viral
This is a "connection" page, showing publications Glenda Gray has written about RNA, Viral.
Connection Strength
0,178
-
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. Lancet Infect Dis. 2011 Jul; 11(7):507-15.
Score: 0,085
-
Antiviral activity of nucleoside analogues during short-course monotherapy or dual therapy: its role in preventing HIV infection in infants. J Acquir Immune Defic Syndr. 2006 Jun; 42(2):169-76.
Score: 0,060
-
Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort. AIDS. 2011 Jan 02; 25(1):87-94.
Score: 0,021
-
Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates. Virus Genes. 2003 Jan; 26(1):49-56.
Score: 0,012